Publication Name	World Journal of Hepatology
Manuscript ID	89551
Country	Japan

Received	2023-11-09 10:52
Peer-Review Started	2023-11-09 10:53
To Make the First Decision
Return for Revision	2023-11-27 07:23
Revised	2023-12-05 10:47
Second Decision	2023-12-12 23:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-12-19 06:32
Articles in Press	2023-12-19 06:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-18 07:20
Publish the Manuscript Online	2024-01-23 09:31

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Metabolomics in liver diseases: A novel alternative for liver biopsy?
Manuscript Source	Invited Manuscript
All Author List	Yasuo Tanaka
ORCID	Author(s) ORCID Number Yasuo Tanaka http://orcid.org/0000-0002-2917-3365
Funding Agency and Grant Number
Corresponding Author	Yasuo Tanaka, MD, PhD, Chief Doctor, Department of Gastroenterology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. ytanaka@hosp.ncgm.go.jp
Key Words	Metabolomics; Hepatitis C virus; Liver fibrosis; Liver cirrhosis; Serum biomarker
Core Tip	Metabolomics, a rapidly emerging technology, offers a non-invasive alternative to conventional blood tests and transient elastography with magnetic resonance imaging or ultrasonography for fibrosis staging. I consider the article titled “Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways” by Ferrasi et al, published in the latest issue of the World Journal of Hepatology. I review prior studies concerning the role of metabolomics in diagnosing HCV-related liver fibrosis and establishing a foundation for non-invasive diagnostic techniques.
Publish Date	2024-01-23 09:31
Citation	Tanaka Y. Metabolomics in liver diseases: A novel alternative for liver biopsy? World J Hepatol 2024; 16(1): 12-16
URL	https://www.wjgnet.com/1948-5182/full/v16/i1/12.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i1.12

Full Article (PDF)	WJH-16-12-with-cover.pdf
Full Article (Word)	WJH-16-12.docx
Manuscript File	89551_Auto_Edited-LJH-YJP.docx
Answering Reviewers	89551-Answering reviewers.pdf
Audio Core Tip	89551-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	89551-Conflict-of-interest statement.pdf
Copyright License Agreement	89551-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	89551-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	89551-Language certificate.pdf
Peer-review Report	89551-Peer-review(s).pdf
Scientific Misconduct Check	89551-Bing-Liu JH-2.png
Scientific Misconduct Check	89551-CrossCheck.png
Scientific Editor Work List	89551-Scientific editor work list.pdf
CrossCheck Report	89551-CrossCheck report.pdf